Democratizing hedge fund level analysis tools for everyone
Name | Merck Tbk. |
Sector | Healthcare |
Industry | Pharmaceuticals & Health Care Research |
Code | F2 |
Latest Quarterly | 06-30-25 |
Name | Latest % | A Month Ago % |
---|---|---|
Merck Holding Gmbh | 74.0 | 74.0 |
Emedia Export Company Mbh | 13.0 | 13.0 |
Public < 5% | 13.0 | 13.0 |
Others | 0.01 | 0.0 |
Source | 2022 | 2021 |
---|---|---|
Biopharma | 73.8% | 65.3% |
Consumer Health | 23.1% | 25.9% |
Other | 3.1% | 8.8% |
Others | 0.0% | 0.0% |
Region | 2022 | 2021 |
---|---|---|
Indonesia | 87.0% | 83.1% |
Offshore Countries | 13.0% | 16.9% |
Others | 0.0% | 0.0% |
Valuation | Ratio | Rank |
---|---|---|
P/S | 1.31 | # 10 / 15 |
EV_EBITDA | 16.77 | # 10 / 15 |
PER | 27.86 | # 10 / 15 |
PBV | 1.49 | # 8 / 15 |
DER | 0.21 | # 2 / 15 |
Profitability | Ratio | Rank |
---|---|---|
NPM % | 4.7 | # 7 / 15 |
ROA % | 4.5 | # 8 / 15 |
ROE % | 5.4 | # 11 / 15 |
Year | DPS | Yield [%] |
---|---|---|
2024 | 320.0 | 8.9 |
2023 | 320.0 | 7.7 |
2022 | 240.0 | 5.1 |
2021 | 122.0 | 3.3 |
2020 | 130.0 | 4.0 |
Timeframe | Performance |
---|---|
1W % | -0.4 |
1Mo % | -3.8 |
3Mo % | -18.2 |
1Yr % | -22.9 |
Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
---|---|---|---|---|---|---|
MERK | 27.86 | 1.30 T | 1.24 T | 960 B | 71 B | 45 B |
KLBF | 16.05 | 66.94 T | 68.47 T | 34,159 B | 5,862 B | 3,950 B |
SIDO | 13.49 | 15.00 T | 14.69 T | 3,657 B | 1,604 B | 1,201 B |
TSPC | 7.31 | 9.97 T | 8.89 T | 13,197 B | 1,807 B | 1,404 B |
SOHO | 16.51 | 8.88 T | 11.01 T | 10,338 B | 711 B | 581 B |
PYFA | -14.31 | 4.94 T | 10.68 T | 2,771 B | -27 B | -426 B |